Inventor · Seattle, WA, US

Mark Litton

22Patents
7h-index
15Co-inventors
62Inventor score

Filing activity: Oct 22, 2004 → Mar 11, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US7906117B2 Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever Chemistry; Metallurgy 53 Active
US8268582B2 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy Chemistry; Metallurgy 49 Active
US8337847B2 Methods of treating anemia using anti-IL-6 antibodies Emerging Cross-Sectional Technologies 48 Active
US7927863B2 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy Chemistry; Metallurgy 29 Active
US9452227B2 Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments Emerging Cross-Sectional Technologies 22 Active
US9724410B2 Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity Emerging Cross-Sectional Technologies 8 Active
US9775921B2 Subcutaneously administrable composition containing anti-IL-6 antibody Emerging Cross-Sectional Technologies 7 Active
US9187560B2 Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever Emerging Cross-Sectional Technologies 6 Active
US9821057B2 Anti-IL-6 antibody for use in the treatment of cachexia Emerging Cross-Sectional Technologies 6 Active
US9546213B2 Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever Chemistry; Metallurgy 5 Active
US10053506B2 Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever Emerging Cross-Sectional Technologies 4 Active
US10160804B2 Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever Chemistry; Metallurgy 2 Active
US10391169B2 Method of treating allergic asthma with antibodies to IL-6 Emerging Cross-Sectional Technologies 2 Active
US10117955B2 Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies Emerging Cross-Sectional Technologies 2 Active
US10640560B2 Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and /or fever Emerging Cross-Sectional Technologies 2 Active
US10155819B2 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy Chemistry; Metallurgy 1 Active
US10259883B2 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy Chemistry; Metallurgy 1 Active
US8709756B2 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy Chemistry; Metallurgy 1 Active
US9873746B2 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy Chemistry; Metallurgy 1 Active
US11447560B2 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy Chemistry; Metallurgy 0 Active
US8900580B2 Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments General 0 Revoked
US8992904B2 Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity General 0 Revoked

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.